Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma

scientific article published on 16 January 2014

Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1050047961
P356DOI10.1007/S13277-014-1612-Y
P698PubMed publication ID24430362
P5875ResearchGate publication ID259766893

P50authorSpyridon ChristodoulouQ47503577
Andreas ScorilasQ40005217
Christos K. KontosQ41025112
Iordanis N. PapadopoulosQ42907857
P2093author name stringDimitra K Alexopoulou
P2860cites workProteinase-activated receptors, targets for kallikrein signalingQ24298638
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarkerQ24648238
Nonparametric Estimation from Incomplete ObservationsQ25938997
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesisQ28138414
Human and mouse proteases: a comparative genomic approachQ28184208
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancerQ28270163
The emerging roles of human tissue kallikreins in cancerQ28290701
PAR1-type thrombin receptor stimulates migration and matrix adhesion of human colon carcinoma cells by a PKCepsilon-dependent mechanismQ28294688
The role of gelatinases in colorectal cancer progression and metastasisQ28297496
In silico analysis of the human kallikrein gene 6.Q33210507
Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancerQ33528155
Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cellsQ33703798
Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicityQ33898352
Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinomaQ43010073
Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).Q43418010
Increased expression of protease M in ovarian tumors.Q43508961
Kallikrein-related peptidase 4 (KLK4) mRNA predicts short-term relapse in colorectal adenocarcinoma patients.Q45909283
A Case–Control Study of Screening Sigmoidoscopy and Mortality from Colorectal CancerQ46030054
Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effectsQ46830854
Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancerQ50357080
Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: mechanistic and clinical aspects.Q53257460
Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.Q53679668
Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.Q53805326
Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.Q54669080
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancerQ57940755
Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour CellsQ57942209
Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian CarcinomaQ57942345
Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinomaQ57942914
KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patientsQ62606052
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancerQ62606054
Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7 & KLK14) in colon cancerQ62606061
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancerQ80157928
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimizationQ80980462
Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasionQ81098053
Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4.Q33919333
Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?Q33939899
Proteinase-activated receptors.Q33947141
Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironmentQ35350228
Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cellsQ35474479
Aberrant Expression and Activation of the Thrombin Receptor Protease-Activated Receptor-1 Induces Cell Proliferation and Motility in Human Colon Cancer CellsQ35749110
High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosisQ35893466
Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.Q35910761
Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2-mediated proliferation of colon cancer cell.Q36012117
Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancerQ36075255
Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and moreQ36519368
Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects.Q36609685
Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinomaQ36965062
Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).Q37216570
Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell linesQ37217423
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancerQ37228450
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinomaQ37400530
New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase familyQ37453804
Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignanciesQ37714914
Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevanceQ38002824
Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkersQ38055059
Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancerQ39527940
The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agents.Q39558472
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.Q39608822
Clinical significance of human kallikrein7 gene expression in colorectal cancerQ39693773
Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancerQ39761179
Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cellsQ39961341
Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cellsQ40011698
Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancerQ40262755
Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colonQ40332571
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancersQ40357075
Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancerQ40366077
Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivationQ40580473
P433issue5
P921main subjectbiomarkerQ864574
P304page(s)4673-4685
P577publication date2014-01-16
P1433published inTumor BiologyQ15757842
P1476titleKallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma
P478volume35

Reverse relations

cites work (P2860)
Q56888917A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering
Q90702145Alternative Splicing Detection Tool-a novel PERL algorithm for sensitive detection of splicing events, based on next-generation sequencing data analysis
Q41823848Detection of Biomarkers with Solid-Phase Proximity Ligation Assay in Patients with Colorectal Cancer
Q54976872Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Q88255485Discovery of novel transcripts of the human tissue kallikrein (KLK1) and kallikrein-related peptidase 2 (KLK2) in human cancer cells, exploiting Next-Generation Sequencing technology
Q92347394Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis
Q26771266Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes
Q47164608Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 - KLK9), using Next-generation sequencing
Q47096307Non-coding RNAs profiling in head and neck cancers.
Q90702126Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer
Q28543174Overexpression of lipocalins and pro-inflammatory chemokines and altered methylation of PTGS2 and APC2 in oral squamous cell carcinomas induced in rats by 4-nitroquinoline-1-oxide
Q35732225Prognostic significance of multiple kallikreins in high-grade astrocytoma
Q90702137Quantitative analysis and study of the mRNA expression levels of apoptotic genes BCL2, BAX and BCL2L12 in the articular cartilage of an animal model of osteoarthritis
Q37711929Transcriptome reveals the overexpression of a kallikrein gene cluster (KLK1/3/7/8/12) in the Tibetans with high altitude-associated polycythemia
Q50203849miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma

Search more.